Benefits
Supports cardiovascular wellness
Selenium yeast paired with coenzyme Q10 has been studied for its role in supporting cardiovascular wellness in older adults. As a trace mineral, selenium helps maintain the body's normal antioxidant systems that protect cells, including those of the heart and blood vessels, from everyday oxidative stress.
Supports antioxidant defenses
Selenium is an essential cofactor for glutathione peroxidase and other selenoenzymes that help neutralize reactive oxygen species. Supplementing with a well-absorbed organic selenium yeast helps maintain selenoprotein activity and supports the body's natural antioxidant capacity.
Promotes healthy aging
Adequate selenium status helps maintain redox balance and normal cellular function that can decline with age. Organic selenium yeast is studied as part of a nutritional approach to support healthy aging and overall vitality in older adults with lower baseline selenium intake.
Helps maintain selenium status
With absorption measured around 89% in humans, this standardized selenium yeast efficiently raises and helps maintain blood selenium levels. Maintaining adequate selenium status supports the many selenium-dependent enzymes involved in antioxidant, thyroid, and immune function.
Supports normal heart muscle function
Selenium and coenzyme Q10 both contribute to normal energy metabolism and antioxidant protection in cardiac tissue. In combination they have been studied for supporting markers of healthy heart muscle function in elderly individuals with low dietary selenium intake.
Mechanism of action
Selenoprotein synthesis
Absorbed selenium is incorporated as selenocysteine into selenoproteins such as glutathione peroxidases and thioredoxin reductases. These enzymes drive the body's antioxidant defenses, helping detoxify peroxides and maintain cellular redox balance throughout tissues.
Antioxidant and redox support
By supplying selenium for glutathione peroxidase activity, selenium yeast supports the breakdown of lipid and hydrogen peroxides. This helps protect cell membranes and lipoproteins from oxidative modification, a process relevant to vascular and overall cellular health.
Synergy with coenzyme Q10
Selenoenzymes such as thioredoxin reductase help keep coenzyme Q10 in its reduced, active ubiquinol form. This interdependence is the proposed rationale for pairing selenium yeast with CoQ10 to jointly support mitochondrial energy production and antioxidant capacity.
High bioavailability of organic selenium
Selenium bound into yeast amino acids, chiefly selenomethionine, is absorbed via amino-acid transport pathways with roughly 89% efficiency. This allows efficient incorporation into the body's selenium pool and tissue selenoproteins compared with poorly retained inorganic forms.
Clinical trials
Randomized, double-blind, placebo-controlled trial; 200 µg/day selenium yeast plus 200 mg/day coenzyme Q10 versus placebo for about 4-5 years.
443 generally healthy Swedish community-dwelling adults aged roughly 70-88 years, many with low baseline dietary selenium intake.
Over about five years, the active group receiving the selenium yeast and coenzyme Q10 combination showed lower cardiovascular mortality and lower NT-proBNP, plus better echocardiographic cardiac function scores, versus placebo. Because both nutrients were given together, the results reflect the combination and cannot be attributed to selenium yeast alone.
Long-term observational follow-up of the original randomized cohort, extending to 10 years after the 4-year supplementation period ended.
The same 443 elderly Swedish participants from the original trial, with complete follow-up and no participants lost.
Reduced cardiovascular mortality in the group that had received selenium yeast plus coenzyme Q10 persisted at 10 years, well after supplementation stopped. The persistence was seen across subgroups. As with the parent trial, the effect reflects the selenium plus CoQ10 combination rather than selenium yeast in isolation.
Extended follow-up to 12 years, validating the earlier 10-year analysis of the randomized, double-blind, placebo-controlled cohort.
The same 443 elderly Swedish participants, including subgroups with ischemic heart disease, diabetes, and hypertension.
Cardiovascular mortality remained significantly lower at 12 years in those originally given the selenium yeast and coenzyme Q10 combination versus placebo, with protective associations across multiple subgroups. The benefit again reflects the combined intervention, not selenium yeast alone.